bibliographic entry 5530271 [be/5530271]
https://w3id.org/oc/corpus/be/5530271

is a
content
  • Rousselot P, Charbonnier A, Cony-Makhoul P, Agape P, Nicolini FE, Varet B et al. Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease. J Clin Oncol 2014; 32: 424–430. PMID: 24323036
references